bioAffinity Technologies Announces Distribution Agreement with AvMEDICAL

What Happened
bioAffinity Technologies, Inc. (the Company) filed a Form 8-K on August 18, 2026 to announce that it has entered into a distribution agreement with AvMEDICAL, a Service-Disabled Veteran-Owned Small Business (SDVSB) that supplies medical and surgical laboratory services, supplies and equipment to government agencies. The Company attached a press release describing the agreement as Exhibit 99.1 to the filing.

Key Details

• Filing: Form 8-K, Item 8.01 (Other Events), filed August 18, 2026.
• Parties: bioAffinity Technologies, Inc. and AvMEDICAL (an established SDVSB distributor to government agencies).
• Disclosure: Press release attached as Exhibit 99.1; the 8-K does not disclose financial terms or revenue projections.

Why It Matters
This agreement could expand bioAffinity’s distribution channels into government and institutional buyers through an SDVSB partner, which may help commercial reach. However, the company did not disclose financial terms or expected timing of any sales, so investors should view this as a strategic distribution development rather than a confirmed revenue driver until more details are provided in future filings or company communications. Monitor future 8-Ks, press releases, or quarterly reports for terms, order volumes, or revenue impact.